問卷

TPIDB > Search Result

Search Result

篩選

List

1336Cases

2016-06-01 - 2023-05-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2017-12-15 - 2020-12-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2007-02-01 - 2009-03-30

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2007-02-01 - 2009-03-30

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2019-12-01 - 2022-12-31

Phase II

Completed
A Study of Nivolumab Combination Gemcitabine and S1 as the First-Line Treatment in Patients With Advanced Biliary Tract Cancer
  • Condition/Disease

    Advanced Biliary Tract Cancer

  • Test Drug

    OPDIVO

Participate Sites
7Sites

Recruiting7Sites

2017-04-01 - 2025-11-04

Phase III

Completed
A randomized, Phase 3, controlled study of a regorafenib-containing regimen versus standard therapy in patients with refractory advanced gastroesophageal cancer (AGOC).
  • Condition/Disease

    Advanced gastroesophageal cancer (AGOC)

  • Test Drug

    Regorafenib (BAY 73-4506)

Participate Sites
5Sites

Recruiting5Sites

2011-10-01 - 2014-12-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Terminated11Sites

2014-01-01 - 2017-12-31

Others

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2016-03-01 - 2020-06-30

Others

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2014-01-01 - 2017-12-31

Others

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites